Update about the Moroccan Society of Pediatric Hematology/Oncology Phase II metronomic trial.

Cure rates in pediatric cancer can reach 80% in high income countries (HIC). However, 80% children are living low income countries where cure rates often don’t exceed 35%. Children with metastatic, unresectable, or recurrent cancer continue to have poor prognosis and the treatment of these patients with second-line intensive or experimental treatments (...)

Update about the pediatric palliative and metronomic program in Dominican Republic

We are happy to share with you the data that Wendy Gómez García has gathered about her metronomic experience as a part of a Palliative Care Pilot Program and Metronomic Therapy being lead at the Dr. Robert Reid Cabral Children’s Hospital in Dominican Republic The metronomic protocol was a 3 drugs protocol with: Ibuprofen 20 mg/Kg/day for 42 days (...)

BARTON KAMEN PRIZE

• Barton Kamen-MGHI Prize : call for abstract
• First Barton Kamen-MGHI prize : Modified COMBAT (Combined Oral Metronomic Biodifferentiating Antiangiogenic Treatment) therapy in poor prognosis pediatric malignant brain tumors
• Metronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential.
• Second Barton Kamen-MGHI prize: call for abstract
• The 2nd Barton Kamen-MGHI Prize has been attributed to Pr G. Saulnier-Sholler : DFMO in Neuroblastoma
• 3rd Karton Kamen-MGHI Prize : call for abstracts